Trial Profile
A Prospective, Multicenter, Feasibility Study of Autologous Muscle-derived Cell (AMDC) Transplantation for Treatment of Advanced Ischemic Heart Failure
Status:
Discontinued
Phase of Trial:
Phase I/II
Latest Information Update: 06 Jul 2021
Price :
$35
*
At a glance
- Drugs Iltamiocel (Primary)
- Indications Ischaemic heart disorders
- Focus Adverse reactions
- Sponsors Cook MyoSite
- 30 Jan 2015 New trial record